Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration. by Denis Mustafov (19137870)

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)

Mod loss is associated with a reduction of central brain NBs. by Amalia S. Parra (4173004)

Subjects:

NBs in Mod-depleted brains display defects in expression of key cell identity factors. by Amalia S. Parra (4173004)

Subjects:

Reproducibility of response time and brain measures. by Jan Willem Koten (17743224)

Mean cocaine consumed (mg/kg) over 10 days. by Christopher Rowan (21499924)

Loss of Mod causes cell cycle defects. by Amalia S. Parra (4173004)

Subjects:

Claudin V is decreased following infection with Mtb. by Amanda S. Latham (12093638)

“…Exposure to Mtb H37Rv and HN878 decreased claudin V expression compared to uninfected controls in the frontal cortex (E), cerebral nuclei (J), brain stem (O), thalamus (T), and hippocampus (Y). …”

SBP3 KD decreases cytoadhesion of iRBCs to bovine brain endothelial cells (BBECs). by Atefeh Fathi (7370876)

Prenatal alcohol exposure (PAE) decreases brain and body weights at E14 and P0. by Danielle Sambo (6077924)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Introgression decreases allelic shuffling. by Enrique J. Schwarzkopf (6579275)

Why does task performance decrease with burst length? by Swathi Anil (17382903)

CS rates increased with protraction and decreased with retraction. by Paul Hage (21071783)

ECoG timescales decrease during spatial attention. by Isabel Raposo (21615517)

Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

“…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”

Mean, confidence intervals (95%) and observed difference for each factor. by Nelyane N. M. Santana (5217074)

Statins resulted in smaller neuronal soma size. by Shuk C. Tsoi (21192243)

“…Areas of all BrdU + /Hu+ neurons measured in control birds (dark orange line) and statin-treated birds (light orange line) shows qualitatively that statins did not decrease soma sizes of small cells (overlap of orange lines), and statins did not curtail the upper limit of soma size (light orange line reaches a soma size of > 200 µm, Y axis, top panel). …”